Economic aspects of shortening the duration of tuberculosis treatment

Malaisamy, Muniyandi and Nagarajan, Karikalan (2024) Economic aspects of shortening the duration of tuberculosis treatment. Economic aspects of shortening the duration of tuberculosis treatment, 12 (6). E901-E902.

Text 202428.pdf - Published Version Download (43kB)

Abstract

With the currently recommended 6-month antituberculosis therapy (ATT), 85% of people with drugsensitive tuberculosis could be cured.1 However, this regimen still requires four medications and a minimum of 6 months of therapy. Long duration of treatment and drug-related toxicity leads to drug fatigue and non-compliance. Recurrence, community transmission, and acquired drug-resistance are all risks associated with premature treatment discontinuation, especially for drug-resistant tuberculosis, which requires more intensive treatment and longer duration.2 The prevailing cost of treatment constrains available resources in lowincome and middle-income countries, and thus shorter regimens for both drug-susceptible and drug-resistant tuberculosis are vital.

Affiliation:	ICMR-National Institute for Research in Tuberculosis
Item Type:	Article
URI:	http://eprints.nirt.res.in/id/eprint/2037

Actions (login required)

View Item